Search

everythinglearnresearchcommunity

for

Search:↓

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Immune cells affect hair growth and could lead to new hair loss treatments.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

ILC1 cells contribute to hair loss in alopecia areata.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Fetal skin has unique immune cells different from adult skin.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.